Anti-BRAF (phospho S729) antibody [EPR2207]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(13 Publications)
Rabbit Recombinant Monoclonal BRAF phospho S729 antibody. Suitable for WB and reacts with Rat samples. Cited in 13 publications.
View Alternative Names
BRAF1, RAFB1, BRAF, Serine/threonine-protein kinase B-raf, Proto-oncogene B-Raf, p94, v-Raf murine sarcoma viral oncogene homolog B1
- WB
Unknown
Western blot - Anti-BRAF (phospho S729) antibody [EPR2207] (AB124794)
All lanes:
Western blot - Anti-BRAF (phospho S729) antibody [EPR2207] (ab124794) at 1/1000 dilution
Lane 1:
PC-12 cell lysates (untreated) at 10 µg
Lane 2:
PC-12 cell lysates treated with Lambda Phosphatase at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 84 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-BRAF (phospho S729) antibody [EPR2207] (AB124794)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-BRAF (phospho S729) antibody [EPR2207] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Nature methods 21:2094-2106 PubMed39433876
2024
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 7:1073 PubMed39217250
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 80:61 PubMed36763212
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:7343 PubMed36446791
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature 609:416-423 PubMed35830882
2022
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy 17:2128-2143 PubMed32866426
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 295:2407-2420 PubMed31929109
2020
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 9:294-303 PubMed30976491
2019
Applications
Unspecified application
Species
Unspecified reactive species
Developmental cell 48:345-360.e7 PubMed30595535
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 25:1501-1510.e3 PubMed30404005
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com